相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life
Dawn C. Buse et al.
MAYO CLINIC PROCEEDINGS (2012)
Co-morbidity of migraine with somatic disease in a large population-based study
Han Le et al.
CEPHALALGIA (2011)
Negative Impact of Episodic Migraine on a University Population: Quality of Life, Functional Impairment, and Comorbid Psychiatric Symptoms
Todd A. Smitherman et al.
HEADACHE (2011)
MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine
Sheena K. Aurora et al.
HEADACHE (2011)
Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migrane und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft fur Neurologie (DGN), the A-sterreichische Kopfschmerzgesellschaft (A-KSG) and the Schweizerische Kopfwehgesellschaft (SKG)
Gunther Haag et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?
John A. Morren et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Employment and Work Impact of Chronic Migraine and Episodic Migraine
Walter F. Stewart et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2010)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism
Robert O. Cook et al.
HEADACHE (2009)
A Randomized, Double Blind, Placebo-Controlled Study of MAP0004 in Adult Patients With Migraine
Sheena K. Aurora et al.
HEADACHE (2009)
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward
P. C. Tfelt-Hansen et al.
CEPHALALGIA (2008)
Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics
Stephen B. Shrewsbury et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms
Daniela Velati et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (Tempo™) Inhaler
Stephen B. Shrewsbury et al.
HEADACHE (2008)
Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up
J. Zidverc-Trajkovic et al.
CEPHALALGIA (2007)
Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review
Michele Fisher et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
The global burden of headache: a documentation of headache prevalence and disability worldwide
L. J. Stovner et al.
CEPHALALGIA (2007)
DHE in the pharmacotherapy of migraine: Potential for a larger role
Joel R. Saper et al.
HEADACHE (2006)
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine
Joel R. Saper et al.
HEADACHE (2006)
Infrequent or non-response to oral sumatriptan does not predict response to other triptans -: review of four trials
CGH Dahlöf
CEPHALALGIA (2006)
Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes
ME Bigal et al.
CEPHALALGIA (2004)
Ergotamine and dihydroergotamine: History, pharmacology, and efficacy
SD Silberstein et al.
HEADACHE (2003)
The outcome of treating patients with suspected rebound headache
JS Warner
HEADACHE (2001)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
分享论文
